These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21302481)

  • 41. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence-based Chinese medicine for rheumatoid arthritis.
    Zhang C; Jiang M; Lü AP
    J Tradit Chin Med; 2011 Jun; 31(2):152-7. PubMed ID: 21977818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The PRECIS-2 tool: designing trials that are fit for purpose].
    Hu GP; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):222-226. PubMed ID: 29495210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thinking and methods in practical assessment of TCM clinical therapeutic effect].
    Shang HC; Zhang BL; Li YP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Mar; 28(3):266-8. PubMed ID: 18476434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Precise reporting of traditional Chinese medicine interventions in randomized controlled trials.
    Bian ZX; Moher D; Li YP; Wu TX; Dagenais S; Cheng CW; Li J; Li TQ
    Zhong Xi Yi Jie He Xue Bao; 2008 Jul; 6(7):661-7. PubMed ID: 18601844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Applying 'technology assessment' and 'evidence based medicine' theory to interventional radiology. Part 1: Suggestions for the phased evaluation of new procedures.
    Malone DE; Maceneaney PM
    Clin Radiol; 2000 Dec; 55(12):929-37. PubMed ID: 11124072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methodological aspects of Traditional Chinese Medicine (TCM).
    Ernst E
    Ann Acad Med Singap; 2006 Nov; 35(11):773-4. PubMed ID: 17160191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Design, implementation and methodological issues in cohort study].
    Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):331-6. PubMed ID: 18405596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features.
    Dal-Ré R; de Boer A; James SK
    J Clin Epidemiol; 2020 Oct; 126():193-201. PubMed ID: 32325221
    [No Abstract]   [Full Text] [Related]  

  • 50. Traditional chinese medicine: an update on clinical evidence.
    Xue CC; Zhang AL; Greenwood KM; Lin V; Story DF
    J Altern Complement Med; 2010 Mar; 16(3):301-12. PubMed ID: 20192915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical trials beyond the German Drug Law. Clinical trials in surgery].
    Seiler CM; Rossion I; Diener MK
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):433-8. PubMed ID: 19277473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The role of integrative medicine in the innovation and development of Chinese medicine].
    Song J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Apr; 29(4):354-6. PubMed ID: 19526765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials.
    Bratton DJ; Nunn AJ
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):440-6. PubMed ID: 21396200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do randomised studies of traditional Asian therapies generate different results than non-randomised trials?
    Ernst E; Lee MS
    Int J Clin Pract; 2014 May; 68(5):655-7. PubMed ID: 24750528
    [No Abstract]   [Full Text] [Related]  

  • 55. The value of information and optimal clinical trial design.
    Willan AR; Pinto EM
    Stat Med; 2005 Jun; 24(12):1791-806. PubMed ID: 15806619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A pragmatic view on pragmatic trials.
    Patsopoulos NA
    Dialogues Clin Neurosci; 2011; 13(2):217-24. PubMed ID: 21842619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Construction and thinking of data element standard directory of traditional Chinese medicine clinical pharmacy information].
    Wang XX; Jin ZZ; Guo GM; Zhai HQ; Jin SY
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1724-7. PubMed ID: 25095392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Qualitative research methods in clinical practice].
    Thörn A; Bunne M; Hallberg H
    Lakartidningen; 2001 Mar; 98(12):1358-63. PubMed ID: 11320783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The importance and necessity of establishing technical specifications for the registration of Traditional Chinese Medicine clinical studies.
    Pengfei L; Xing L; Yanming X; Zhiguo W
    J Altern Complement Med; 2014 Jan; 20(1):65-6. PubMed ID: 24351024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.